IOCB projects selected for oral presentation and Spin-off panel at BioVaria 2016


IOCB’s Lipeon project was selected for the Spin-off Panel at this years BioVaria conference May 17th 2016 in Munich, Germany

BioVaria brings together European research institutions across national borders in order to improve the transfer of their research results into application. In just one day,

it presents an unmatched density of highly innovative technologies to potential investors, collaboration partners and  licensees from the international bio-pharmaceutical industry.

IOCB’s iBodies and DIANA projects are selected for oral presentation at this years BioVaria conference May17th 2016 in Munich, Germany. So if you are around come and follow the presentation of Vaclav Navratil and Tomas Knedlik from 3pm, here is the link to the preliminary Program. If you like to read more about our iBodies project please visit or

IOCB and IOCB-TTO will be present with five technologies. IOCB-TTO will have a booth at BioVaria with all five technologies presented as posters. So if you are interested to learn more about what we are doing, please come and see us in Munich, Germany May 17th 2016.

Furthermore, our Lipeon project was selected for the Spin-off panel at BioVaria. LIPEON THERAPEUTICS is a spin-off in preparation with the aim to secure financing for development of a novel molecule to treat diabetes Type 2 and obesity. Our candidate molecule improves glycemic and weight parameters by a unique mechanism of action targeting multiple relevant receptors. To find out more about Lipeon Therapeutics and the team behind come and meet us at BioVaria in Munich or get in contact with us via email or phone +420 220 612 258.Logo-iBodies-RGB